HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging.

Abstract
Oculopharyngeal muscular dystrophy (OPMD) is caused by trinucleotide repeat expansion mutations in Poly(A) binding protein 1 (PABPN1). PABPN1 is a regulator of mRNA stability and is ubiquitously expressed. Here we investigated how symptoms in OPMD initiate only at midlife and why a subset of skeletal muscles is predominantly affected. Genome-wide RNA expression profiles from Vastus lateralis muscles human carriers of expanded-PABPN1 at pre-symptomatic and symptomatic stages were compared with healthy controls. Major expression changes were found to be associated with age rather than with expression of expanded-PABPN1, instead transcriptomes of OPMD and elderly muscles were significantly similar (P<0.05). Using k-means clustering we identified age-dependent trends in both OPMD and controls, but trends were often accelerated in OPMD. We report an age-regulated decline in PABPN1 levels in Vastus lateralis muscles from the fifth decade. In concurrence with severe muscle degeneration in OPMD, the decline in PABPN1 accelerated in OPMD and was specific to skeletal muscles. Reduced PABPN1 levels (30% to 60%) in muscle cells induced myogenic defects and morphological signatures of cellular aging in proportion to PABPN1 expression levels. We suggest that PABPN1 levels regulate muscle cell aging and OPMD represents an accelerated muscle aging disorder.
AuthorsSeyed Yahya Anvar, Yotam Raz, Nisha Verway, Barbara van der Sluijs, Andrea Venema, Jelle J Goeman, John Vissing, Silvère M van der Maarel, Peter A C 't Hoen, Baziel G M van Engelen, Vered Raz
JournalAging (Aging (Albany NY)) Vol. 5 Issue 6 Pg. 412-26 (Jun 2013) ISSN: 1945-4589 [Electronic] United States
PMID23793615 (Publication Type: Journal Article)
Chemical References
  • PABPN1 protein, human
  • Poly(A)-Binding Protein I
  • RNA, Messenger
Topics
  • Adolescent
  • Adult
  • Aged, 80 and over
  • Aging (physiology)
  • Animals
  • Case-Control Studies
  • Cellular Senescence
  • Gene Expression Regulation (physiology)
  • Humans
  • Mice
  • Middle Aged
  • Muscle Weakness (genetics, metabolism)
  • Muscle, Skeletal (metabolism)
  • Muscular Dystrophy, Oculopharyngeal (genetics, metabolism)
  • Poly(A)-Binding Protein I (genetics, metabolism)
  • RNA, Messenger (genetics, metabolism)
  • Transcriptome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: